Mary Crowley Cancer Research

Our Needs

Mary Crowley works to find potentially curative treatments for cancer patients through clinical trial testing. Our patient-specific approach uniquely aligns an individual's cancer with the newest discoveries in personalized genomic and immune therapies. Our goal is to dramatically improve patient survival with the use of personalized treatments, in addition to moving science forward to advance better treatments for cancer patients worldwide. Through our Innovative Clinical Trials program we bring these new trials into the clinic and match them to specific patients' molecular profiles. Successfully recruiting these new targeted therapies takes time, resources, and funding to develop the correct protocol for drug delivery and patient enrollment to satisfy FDA requirements. It costs Mary Crowley Cancer Research approximately $50,000 of unreimbursed expenses to open a new clinical trial. Your support will help us open a new clinical trial for future patients.